InvestorsHub Logo
Followers 87
Posts 6693
Boards Moderated 1
Alias Born 09/18/2009

Re: sosjtb post# 41032

Sunday, 11/12/2023 11:16:58 PM

Sunday, November 12, 2023 11:16:58 PM

Post# of 42926
Yes, I know we have talked about the unchecked boxes before, but also noted the discussion in the next section of the Q somehow seemed to address that issue, as I recall (vaguely).

The reason I am glad someone asked about the recall of the loaned shares is because it gave me the chance to re-post some of the events that transpired the first time the loaned shares were recalled. Board resignations figured into that situation, too.

And not only did management fail to fight this delisting, they voluntarily provided information stating that they did not see a course to meet listing standards in the time they still had available to do so, and bowed out of consideration early.

I interpret this as management's effort to move us to the Expert Market.

To me, this was a contingency move to be able to create shareholder value by recalling the loaned shares while on the Expert Market, in case we still fail to gain regulatory approval. Management is now positioned to force buy-ins from short sellers, and they will have to buy shares from management, at the price level management will demand. That's why I asked them to establish a minimum sell price of $201. Maybe this will give me a chance to fill sell orders at $200 and $250, once Schwab can permit selling.

But it gets far better than that. I feel certain that we WILL gain regulatory approval to use lenz for the treatment of covid, as well as a vaccine adjuvant to use lenz to prevent covid, and to also use lenz to treat CMML.

This share price explosion will be unlike anything seen before! We just need to slide back to OTC Pink or Venture, on our way back to Nasdaq.